Allergy Therapeutics PLC (LON:AGY)

Allergy Therapeutics PLC (LON:AGY)

Share Price
11.50 p
-0.25 (-2.13 %)
Market Cap
£73.16 m
Proactive Investors - Run By Investors For Investors

Allergy Therapeutics PLC

We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.

Market: AIM:AGY
52-week High/Low: 28.000p / 8.000p
Sector: Pharma & Biotech
Market Cap: £73.16 m
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Allergy Therapeutics PLC

Allergy Therapeutics PLC Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use